Wehrens et al. 10.1073/pnas.0500353102.

Supporting Information

Files in this Data Supplement:

Supporting Table 1
Supporting Figure 6




Supporting Figure 6

Fig. 6. Increased calstabin-1 binding to skeletal muscle ryanodine receptor (RyR)1 channels after treatment with JTV519. (A) Binding curves of 35S-labeled calstabin-1 to nonphosphorylated or phosphorylated RyR1 in the presence or absence of JTV519. For comparison, binding curves are shown for calstabin-2 and RyR2. (B) WT RyR2 channels were phosphorylated by protein kinase A (PKA) in the absence or presence of PKI5-24 and incubated with calstabin-2 (Left) or calstabin-1 (Right) in the presence of JTV519 at the indicated concentrations. Immunoblot shows the amounts of calstabin associated with immunoprecipitated RyR after incubation with the indicated concentrations of JTV519.